Disease Overview：Chronic dacryocystitis（CDC）
Chronic dacryocystitis is a persistent inflammatory condition of the lacrimal sac, typically resulting from long-standing nasolacrimal duct obstruction. It manifests with recurrent epiphora (excessive tearing), mucopurulent discharge, and intermittent swelling or tenderness over the medial canthus. Unlike acute presentations, chronic dacryocystitis often lacks systemic symptoms but carries risks of complications, conjunctivitis, and, rarely, orbital cellulitis or abscess formation—if left untreated. Diagnosisrimal irrigation testing, dacryoendoscopy, and imaging such as CT dacryocystographyical patency and identify stenosis, diverticula, or stones. First-line management includes conservative measures like warm compresses and topical antibiotics; however, definitive treatment requires surgical intervention—most commonly endoscopic dacryocystorhinostomy (DCR), which creates a new drainage pathway between the lacrimal sac and nasal cavity while preserving natural anatomy and minimizing external scarring.
China offers distinct-quality care for chronic dacryocystitis. The country’s leading ophthalmology centers—many affiliated with top-tier universities—employ board-certified oculoplastic surgeons with extensive experience in minimally invasive endoscopic D. State-of-the-art intraoperative navigation systems, high-definition endoscopes, and intraoperative CT integration enhance outcomes consistently demonstrate >92% functional success at 12 months, supported by robust published case series from institutionsphthalmic Center and Shanghai Eye & ENT Hospital. Importantly, treatment costs—including surgery, diagnostics, and postoperative care—are typically 40–60% lower, or Germany, without compromising safety or efficacy.
As a dedicated medical tourism agency, we facilitate seamless access to these specialized services for international patients. We coordinate hospital appointments with verified specialists, provide itemized, transparent pricing in advance, assist accommodation and local transport, and offer bilingual clinical support throughout the care journey—from pre-consultation to follow-up coordination.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Chronic Dacryocystitis
Non-Surgical / Conservative Management
*Indicated for mild, non-obstructive cases with intermittent epiphora and minimal purulent discharge; contraindicated in acute exacerbation or complete nasolacrimal duct obstruction.*
- •Diagnostic Workup:
- Nasolacrimal duct probing under topical anesthesia: $32–$45 - High-resolution CT dacryocystography (if anatomical ambiguity): $120–$165
- •Medical Therapy:
- Oral amoxicillin-clavulanate (7-day course, 625 mg BID): $10–$15 - Warm compress + digital massage (home-based, no charge)
Surgical / Procedural Interventions
*Eligibility: Persistent epiphora >3 months, recurrent purulent discharge, confirmed nasolacrimal duct obstruction on irrigation/CT, failure of ≥2 antibiotic courses.*
- •Dacryocystorhinostomy (DCR) — Gold standard:
- External DCR (skin incision, higher success in complex anatomy): $1,620–$2,380
- •Preoperative Workup (mandatory):
- Pre-anesthesia evaluation (ECG, CBC, coagulation panel): $65–$90 - Chest X-ray (if age ≥60 or comorbid respiratory disease): $28–$38
Special / Complex Condition Management
- •Recurrent DCR failure (≥2 prior procedures): Endoscopic revision + silicone intubation + mitomycin C application: $2,550–$3,400
- •Dacryolithiasis with cystic dilation: Dacryocystectomy + stone extraction: $1,850–$2,620
- •Malignancy-suspected lesions (e.g., persistent mass, bloody discharge): Biopsy + frozen-section analysis + oncology referral: $2,900–$4,100
Quick Selection Guide
- •Elderly patients (>75 years) with mild symptoms & multiple comorbidities: Start with conservative therapy ($18–$45 initial workup); avoid surgery unless severe functional impairment.
- •Working-age adults (<60) with moderate-severe obstruction: Proceed directly to endoscopic DCR ($1,480–$2,150); highest cost-effectiveness ratio over 5-year horizon.
- •Budget-constrained patients (<$500 total): Prioritize lacrimal irrigation + probing + oral antibiotics ($100–$220 total); accept 30–40% recurrence risk.
- •Patients with prior sinus surgery or nasal polyposis: External DCR preferred ($1,620–$2,380); endoscopic approach carries higher intraoperative revision risk.
- •Pregnant or lactating women: Conservative management only; defer surgery until postpartum (≥6 weeks after delivery).
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Chronic dacryocystitis Medical Vacation Packages
Curated transparent all-inclusive packages combining Chronic dacryocystitis treatment with China top medical destinations:
